Infarto agudo del miocardio: el factor tiempo

Thrombolytic agents and primary angioplasty (ACP) are two well defined methods for the treatment of patients with ST segment elevation myocardial infarction (STEMI). The use of both methods consecutively, called facilitated angioplasty, is a third alternative, that offers few advantages and is restr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Kauffmann Q,Ronald
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2008
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000900001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872008000900001
record_format dspace
spelling oai:scielo:S0034-988720080009000012008-11-12Infarto agudo del miocardio: el factor tiempoKauffmann Q,Ronald Angioplasty Myocardial infarction Thrombolytic therapy Thrombolytic agents and primary angioplasty (ACP) are two well defined methods for the treatment of patients with ST segment elevation myocardial infarction (STEMI). The use of both methods consecutively, called facilitated angioplasty, is a third alternative, that offers few advantages and is restricted to a small group of patients. The experience abroad demonstrated that ACP offers a higher reduction in mortality than thrombolysis. This is also the case in a national repon published in this issue, showing that hospital mortality of patients treated with thrombolysis and ACP was 10.5% and 5.6%, respectively (p <0.01). The figures for long term mortality were 20.4% and 9.7%, respectively (p <0.01). The crucial factor to improve the treatment results in myocardial infarction in to reduce the time of total ischemia, from the onset ofsymptoms to the start of reperfusion therapy Nowadays, the therapeutic challenges, besides improving percutaneous and pharmacological interventions, are to achieve an early consultation and to reduce institutional timing.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.9 20082008-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000900001es10.4067/S0034-98872008000900001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Angioplasty
Myocardial infarction
Thrombolytic therapy
spellingShingle Angioplasty
Myocardial infarction
Thrombolytic therapy
Kauffmann Q,Ronald
Infarto agudo del miocardio: el factor tiempo
description Thrombolytic agents and primary angioplasty (ACP) are two well defined methods for the treatment of patients with ST segment elevation myocardial infarction (STEMI). The use of both methods consecutively, called facilitated angioplasty, is a third alternative, that offers few advantages and is restricted to a small group of patients. The experience abroad demonstrated that ACP offers a higher reduction in mortality than thrombolysis. This is also the case in a national repon published in this issue, showing that hospital mortality of patients treated with thrombolysis and ACP was 10.5% and 5.6%, respectively (p <0.01). The figures for long term mortality were 20.4% and 9.7%, respectively (p <0.01). The crucial factor to improve the treatment results in myocardial infarction in to reduce the time of total ischemia, from the onset ofsymptoms to the start of reperfusion therapy Nowadays, the therapeutic challenges, besides improving percutaneous and pharmacological interventions, are to achieve an early consultation and to reduce institutional timing.
author Kauffmann Q,Ronald
author_facet Kauffmann Q,Ronald
author_sort Kauffmann Q,Ronald
title Infarto agudo del miocardio: el factor tiempo
title_short Infarto agudo del miocardio: el factor tiempo
title_full Infarto agudo del miocardio: el factor tiempo
title_fullStr Infarto agudo del miocardio: el factor tiempo
title_full_unstemmed Infarto agudo del miocardio: el factor tiempo
title_sort infarto agudo del miocardio: el factor tiempo
publisher Sociedad Médica de Santiago
publishDate 2008
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000900001
work_keys_str_mv AT kauffmannqronald infartoagudodelmiocardioelfactortiempo
_version_ 1718436399907078144